Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report

被引:13
|
作者
Mohty, M
Faucher, C
Gaugler, B
Vey, N
Sainty, D
Arnoulet, C
Mozziconacci, MJ
Isnardon, D
Gastaut, JA
Maraninchi, D
Olive, D
Blaise, D
机构
[1] Inst J Paoli I Calmettes, Unite Transplantat & Therapie Cellulaire, F-13273 Marseille, France
[2] Univ Mediterranee, Inst J Paoli I Calmettes, Lab Immunol Tumeurs, Marseille, France
[3] INSERM, U119, F-13258 Marseille, France
[4] Univ Mediterranee, Inst J Paoli I Calmettes, Dept Hematol, Marseille, France
关键词
LGL; anti-tumor activity; allo-BMT; non-myeloablative; GVT;
D O I
10.1038/sj.bmt.1703308
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
We report here the first case of large granular lymphocytes (LGL) expansion following non-myeloablative allo-BMT for chronic myeloid leukemia. We characterized the morphologic, phenotypic and functional features of the LGL subset amplified in vivo 14 months after allo-BMT. Our results indicate that LGL can mediate in vitro a cytolytic activity on tumor cells. In vivo, the timing of the LGL expansion was associated with a sustained complete molecular remission. These observations suggest that LGL are a subset with the properties of effector lymphocytes which may contribute to the graft-versus-tumor effect.
引用
收藏
页码:1157 / 1160
页数:4
相关论文
共 50 条
  • [1] Large granular lymphocytes (LGL) following non-myeloablative allogeneic bone marrow transplantation: a case report
    M Mohty
    C Faucher
    B Gaugler
    N Vey
    D Sainty
    C Arnoulet
    MJ Mozziconacci
    D Isnardon
    JA Gastaut
    D Maraninchi
    D Olive
    D Blaise
    [J]. Bone Marrow Transplantation, 2001, 28 : 1157 - 1160
  • [2] Non-myeloablative bone marrow transplantation
    Ruiz-Argüelles, GJ
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2003, 34 (06) : 554 - 557
  • [3] Radioimmunotherapy as non-myeloablative conditioning for allogeneic marrow transplantation
    Bethge, Wolfgang A.
    Wilbur, D. Scott
    Sandmaier, Brenda M.
    [J]. LEUKEMIA & LYMPHOMA, 2006, 47 (07) : 1205 - 1214
  • [4] Allogeneic bone marrow transplantation with non-myeloablative conditioning in primary severe immunodeficiences - the report of two cases
    Krasowska-Kwiecien, Aleksandra
    Gozdzik, Jolanta
    Skoczen, Szymon
    Wedrychowicz, Anna
    Czogala, Wojciech
    Wiecha, Oktawiusz
    [J]. BONE MARROW TRANSPLANTATION, 2008, 42 : S120 - S120
  • [5] ALLOGENEIC BONE MARROW TRANSPLANTATION WITH NON-MYELOABLATIVE CONDITIONING IN PRIMARY SEVERE IMMUNODEFICIENCIES - THE REPORT OF TWO CASES
    Krasowska-Kwiecien, A.
    Gozdzik, J.
    Skoczen, Sz.
    Wedrychowicz, A.
    Wiecha, O.
    Czogala, W.
    Majka, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 494 - 494
  • [6] Risk factors for acute graft versus host disease following allogeneic non-myeloablative bone marrow transplantation.
    George, RT
    Sykes, M
    Spitzer, TR
    [J]. JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S374 - S375
  • [7] Non-myeloablative bone marrow transplantation in the treatment of refractory lymphomas
    Sykes, M
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2000, 23 (03): : A12 - A12
  • [8] RAPID REAPPEARANCE OF LARGE GRANULAR LYMPHOCYTES (LGL) AFTER HUMAN-BONE MARROW TRANSPLANTATION (BMT)
    TILG, H
    NIEDERWIESER, D
    GASTL, G
    AULITZKY, W
    RUMPHOLD, H
    MARTH, C
    KRAFT, D
    HUBER, C
    [J]. BONE MARROW TRANSPLANTATION, 1988, 3 : 330 - 330
  • [9] Non-myeloablative allogeneic transplantation for hematologic malignancy
    Forman, S
    [J]. EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 104 - 104
  • [10] Unrelated allogeneic non-myeloablative bone marrow transplant is feasible and effective.
    Emmanouilides, C
    Touroutoglou, N
    Diamandidis, D
    Fayad, L
    Wolf, C
    Territo, M
    [J]. BLOOD, 2000, 96 (11) : 360B - 360B